Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (696)	6/25/2001 2:47:49 PM
From: tuck	Respond to of 1784

Trickle continues manic phase, buys 100 MDCC @$16.75. New low. Unless earnings are absolutely horrific, this ought to hold somewhere around here. Edit: And a small plug for DPII, via CBSMarketWatch: >>WASHINGTON (CBS.MW) -Bill Nasgovitz has a knack for finding dirt-cheap stocks for value-hunting, long-term investors. The $973 million Heartland Value Fund (HRTVX: news, msgs, alerts) has treated its investors to a 22.68 percent return on its small-cap value plays, while the S&P 500 Index is down about 7 percent. Over the past three years, it's returned an annualized 10.3 percent, compared with 4.2 percent for the index. Another favorite is Discovery Partners International (DPII: news, msgs, alerts) , which provides drug discovery products and components to pharmaceutical companies. "It's a solid investment for a long-term investor because the industry is going to grow and this company could grow with it," Nasgovitz said. Its shares were up 2 cents to $5.<< snip along with other paragraphs mentioning non-Trickle -- indeed non-biotech -- companies Cheers, Tuck